Integrated BioPharma Inc (INBP) stock
INBPOTCPharmaceutical PreparationsFiscal year ends June 30
$0.18+0.00 (0.00%)
Close on Oct 19, 2026Market cap $5.59MP/E –Yield –
Integrated BioPharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Integrated BioPharma's pe ratio was 16.6× on Jan 30, 2026, against 19.5× a year earlier. Over the last 5 years it ranged from 2.3× to 86.0×, with a median of 5.8×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 16.6× | −1.1 |
| 2025 | Dec 31, 2025 | 17.8× | +1.3 |
| 2024 | Dec 31, 2024 | 16.5× | +8.2 |
| 2023 | Dec 29, 2023 | 8.3× | +5.2 |
| 2022 | Dec 30, 2022 | 3.2× | −1.2 |
| 2021 | Dec 31, 2021 | 4.3× | −0.6 |
| 2020 | Dec 31, 2020 | 4.9× | +0.8 |
| 2019 | Dec 31, 2019 | 4.2× | −10.8 |
| 2018 | Dec 31, 2018 | 15.0× | +9.0 |
| 2017 | Dec 29, 2017 | 6.0× | +2.7 |
| 2016 | Dec 30, 2016 | 3.3× | −6.7 |
| 2015 | Dec 31, 2015 | 10.0× | +2.0 |
| 2014 | Dec 31, 2014 | 8.0× | +4.2 |
| 2013 | Dec 31, 2013 | 3.8× | – |
See a number that looks wrong?